S&P 500   3,363.50 (+0.84%)
DOW   27,763.42 (+1.13%)
QQQ   279.61 (+1.33%)
AAPL   116.60 (+2.20%)
MSFT   210.65 (+1.64%)
FB   263.25 (+0.56%)
GOOGL   1,478.32 (+0.84%)
AMZN   3,177.63 (+1.04%)
TSLA   428.50 (+2.25%)
NVDA   541.65 (+2.39%)
BABA   291.46 (+5.25%)
CGC   14.39 (-0.76%)
GE   6.24 (+1.96%)
MU   47.56 (-6.21%)
AMD   82.42 (+0.79%)
T   28.49 (+0.67%)
F   6.66 (+0.91%)
ACB   4.67 (-0.21%)
GILD   63.09 (+1.59%)
NFLX   502.01 (+1.73%)
DIS   124.52 (-0.70%)
BA   166.73 (+1.91%)
BAC   24.08 (+1.30%)
S&P 500   3,363.50 (+0.84%)
DOW   27,763.42 (+1.13%)
QQQ   279.61 (+1.33%)
AAPL   116.60 (+2.20%)
MSFT   210.65 (+1.64%)
FB   263.25 (+0.56%)
GOOGL   1,478.32 (+0.84%)
AMZN   3,177.63 (+1.04%)
TSLA   428.50 (+2.25%)
NVDA   541.65 (+2.39%)
BABA   291.46 (+5.25%)
CGC   14.39 (-0.76%)
GE   6.24 (+1.96%)
MU   47.56 (-6.21%)
AMD   82.42 (+0.79%)
T   28.49 (+0.67%)
F   6.66 (+0.91%)
ACB   4.67 (-0.21%)
GILD   63.09 (+1.59%)
NFLX   502.01 (+1.73%)
DIS   124.52 (-0.70%)
BA   166.73 (+1.91%)
BAC   24.08 (+1.30%)
S&P 500   3,363.50 (+0.84%)
DOW   27,763.42 (+1.13%)
QQQ   279.61 (+1.33%)
AAPL   116.60 (+2.20%)
MSFT   210.65 (+1.64%)
FB   263.25 (+0.56%)
GOOGL   1,478.32 (+0.84%)
AMZN   3,177.63 (+1.04%)
TSLA   428.50 (+2.25%)
NVDA   541.65 (+2.39%)
BABA   291.46 (+5.25%)
CGC   14.39 (-0.76%)
GE   6.24 (+1.96%)
MU   47.56 (-6.21%)
AMD   82.42 (+0.79%)
T   28.49 (+0.67%)
F   6.66 (+0.91%)
ACB   4.67 (-0.21%)
GILD   63.09 (+1.59%)
NFLX   502.01 (+1.73%)
DIS   124.52 (-0.70%)
BA   166.73 (+1.91%)
BAC   24.08 (+1.30%)
S&P 500   3,363.50 (+0.84%)
DOW   27,763.42 (+1.13%)
QQQ   279.61 (+1.33%)
AAPL   116.60 (+2.20%)
MSFT   210.65 (+1.64%)
FB   263.25 (+0.56%)
GOOGL   1,478.32 (+0.84%)
AMZN   3,177.63 (+1.04%)
TSLA   428.50 (+2.25%)
NVDA   541.65 (+2.39%)
BABA   291.46 (+5.25%)
CGC   14.39 (-0.76%)
GE   6.24 (+1.96%)
MU   47.56 (-6.21%)
AMD   82.42 (+0.79%)
T   28.49 (+0.67%)
F   6.66 (+0.91%)
ACB   4.67 (-0.21%)
GILD   63.09 (+1.59%)
NFLX   502.01 (+1.73%)
DIS   124.52 (-0.70%)
BA   166.73 (+1.91%)
BAC   24.08 (+1.30%)
Log in
NASDAQ:SGRY

Surgery Partners Stock Forecast, Price & News

$22.37
+2.74 (+13.96 %)
(As of 09/30/2020 02:28 PM ET)
Add
Compare
Today's Range
$20.26
Now: $22.37
$23.06
50-Day Range
$17.79
MA: $20.14
$23.75
52-Week Range
$4.00
Now: $22.37
$24.75
Volume14,085 shs
Average Volume702,782 shs
Market Capitalization$1.13 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.5
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and a suite of ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of December 31, 2018, the company owned or operated a portfolio of 123 surgical facilities, including 108 ambulatory surgical centers and 15 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Read More
Surgery Partners logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.25 out of 5 stars


Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.83 billion
Cash Flow$0.52 per share
Book Value$19.67 per share

Profitability

Net Income$-74,800,000.00

Miscellaneous

Employees9,600
Market Cap$1.13 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$22.37
+2.74 (+13.96 %)
(As of 09/30/2020 02:28 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

How has Surgery Partners' stock price been impacted by Coronavirus (COVID-19)?

Surgery Partners' stock was trading at $8.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SGRY shares have increased by 152.5% and is now trading at $22.37.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Surgery Partners?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Surgery Partners
.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Surgery Partners
.

How were Surgery Partners' earnings last quarter?

Surgery Partners Inc (NASDAQ:SGRY) announced its quarterly earnings data on Wednesday, August, 5th. The company reported ($0.55) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.57) by $0.02. The firm had revenue of $374.70 million for the quarter, compared to analyst estimates of $370.17 million. Surgery Partners had a negative net margin of 5.26% and a negative return on equity of 3.23%.
View Surgery Partners' earnings history
.

What price target have analysts set for SGRY?

5 equities research analysts have issued 1 year price targets for Surgery Partners' stock. Their forecasts range from $17.50 to $28.00. On average, they expect Surgery Partners' share price to reach $23.30 in the next year. This suggests a possible upside of 4.2% from the stock's current price.
View analysts' price targets for Surgery Partners
.

Are investors shorting Surgery Partners?

Surgery Partners saw a decline in short interest during the month of August. As of August 14th, there was short interest totaling 2,550,000 shares, a decline of 23.0% from the July 30th total of 3,310,000 shares. Based on an average trading volume of 589,600 shares, the days-to-cover ratio is presently 4.3 days. Approximately 11.2% of the company's stock are short sold.
View Surgery Partners' Short Interest
.

Who are some of Surgery Partners' key competitors?

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT), Opko Health (OPK), REDHILL BIOPHAR/S (RDHL) and Tesla (TSLA).

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the following people:
  • Mr. Wayne Scott DeVeydt, CEO & Director (Age 49)
  • Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 47)
  • Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 48)
  • Dr. Angela Justice Ph.D., Exec. VP & Chief HR Officer (Age 46)
  • Mr. George M. Goodwin, Pres of American Group (Age 58)

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $22.37.

How big of a company is Surgery Partners?

Surgery Partners has a market capitalization of $1.13 billion and generates $1.83 billion in revenue each year. The company earns $-74,800,000.00 in net income (profit) each year or ($1.10) on an earnings per share basis. Surgery Partners employs 9,600 workers across the globe.

What is Surgery Partners' official website?

The official website for Surgery Partners is www.surgerypartners.com.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.